Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery

NCT02496065 is registered in ClinicalTrials.gov with Blaze Bioscience Inc. as lead sponsor.

NCT NCT02496065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02496065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery
Lead sponsor
Blaze Bioscience Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2015
Completion date
January 31, 2017
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tumors, breast